Boston Scientific warns cyberattack will likely hit Q3 and full-year 2026 results
Boston Scientific disclosed in a September 7 SEC filing that a cyberattack it suffered last month is expected to have a material impact on its third‑quarter and full‑year 2026 financial results.
The company now believes it is unlikely to meet the net‑sales growth and adjusted earnings‑per‑share guidance it had set for both periods.
It said progress is being made to restore global operations, with sterilization facilities back online and manufacturing resuming at most sites, though the full extent of the revenue loss remains uncertain.
Shares fell about 4% after markets reopened following Labor Day as investors reacted to the news.
This writeup was produced by pharmadog from original reporting by Fierce Biotech.
Original headline: “Boston Scientific cyberattack likely to have ‘material impact’ on financial results”
read at Fierce Biotech ↗
comments(0)
5-min edit window · permanent after that